Clinical Trial: Autologous Adipose Derived Mesenchymal Stem Cells for Chronic Traumatic Brain Injury
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: Traumatic Brain Injury
Study Type: INTERVENTIONAL
Official Title: Autologous Adipose Derived Mesenchymal Stem Cells for Chronic Traumatic Brain Injury
Brief Summary:
The global objective of this study is to establish the safety and investigate the potential treatment effect of an intravenous infusion of HB-adMSCs (Hope Biosciences adipose-derived mesenchymal stem cells) on brain structure, neurocognitive/functional outcomes, and neuroinflammation after traumatic brain injury and/or hypoxic-ischemic encephalopathy in adults.
Read more